Subscribe to RSS
DOI: 10.1055/s-2005-872942
Georg Thieme Verlag KG Stuttgart · New York
Fallopian Tube Carcinoma - a Rare Gynaecological Malignancy - Case Report and Review of Literature
Das Tubenkarzinom - ein seltenes gynäkologisches Malignom Fallbericht und LiteraturübersichtPublication History
Eingang Manuskript: 16.9.2005
Akzeptiert: 5.10.2005
Publication Date:
18 January 2006 (online)
Zusammenfassung
Das Tubenkarzinom ist das seltenste gynäkologische Malignom und umfasst 0,1 - 1 % der Tumoren des weiblichen Genitaltrakts. Es wird selten präoperativ diagnostiziert, meist erfolgt eine Operation aus anderer Ursache. Fallbericht: 56-jährige postmenopausale Patientin mit primärem Tubenkarzinom im Stadium III, Begrenzung auf die rechte Tube - ein positiver retroperitonealer Lymphknoten. Nach Resektion wurde eine adjuvante Chemotherapie mit 6 Zyklen Carboplatin/Taxol empfohlen. Schlussfolgerung: Aufgrund der Seltenheit des Tubenkarzinoms sind randomisierte Studien zur Therapiefestlegung schwierig.
Abstract
Background: Primary fallopian tube carcinoma is the rarest of all gynaecological malignancies. It comprises only 0.1 - 1.0 % of all neoplasms of the female genital tract, although it is a common site of metastases. This carcinoma is rarely diagnosed preoperatively; most often patients undergo surgery for other reasons. Case: We report the case of a 56-year-old postmenopausal woman with primary fallopian tube carcinoma third stage confined to the right tube involving one positive retroperitoneal lymph node. Adjuvant chemotherapy with six cycles of Carboplatin/Taxol was advised after surgical resection. Conclusion: The rarity of the condition makes it difficult to perform randomised studies which could determine the treatment of choice. Our work adds further information to the relatively small body of literature available on fallopian tube carcinoma.
Schlüsselwörter
Tubenkarzinom - Stadium III - Adenokarzinom des Eileiters
Key words
Fallopian tube carcinoma - tube cancer - third stage - adeoncarcinoma of the fallopian tube
References
- 1 Rosenblatt K A, Weiss N S, Schwartz S M. Incidence of malignant fallopian tube tumors. Gynecol Oncol. 1989; 35 236-239
- 2 Roberts J A, Lifshitz S. Primary adenocarcinoma of the fallopian tube. Gynecol Oncol. 1982; 13 301-308
- 3 King A, Seraj I M, Thrasher T, Slater J, Wagner R J. Fallopian tube carcinoma: a clinicopathological study of 17 cases. Gynecol Oncol. 1989; 33 351-355
- 4 Rosen A C, Klein M, Rosen H R, Graf A H, Lahousen M, Reiner A, Vavra N, Auerbach L. Preoperative and postoperative CA‐125 serum levels in primary fallopian tube carcinoma. Arch Gynecol Obstet. 1994; 255 65-68
- 5 Sedlis A. Primary carcinoma of the fallopian tube. Obstet Gynecol Surv. 1961; 16 209-226
- 6 Johnson G A. Primary malignancy of the fallopian tube: a clinical review of 13 cases. J Surg Oncol. 1983; 24 304
- 7 Mikami M, Tei C, Kurahashi T, Takehara K, Komiyama S, Suzuki A, Kishikawa T, Fukuiya T. Preoperative diagnosis of fallopian tube cancer by imaging. Abdom Imaging. 2003; 28 743-747
- 8 Nordin A. Primary carcinoma of the fallopian tube: a 20 year literature review. Obstet Gynecol Surv. 1994; 49 349-361
- 9 Aziz S, Kuperstein G, Rosen B, Cole D, Nedelcu R, McLaughlin J, Narod S A. A genetic epidemiological study of carcinoma of the fallopian tube. Gynecol Oncol. 2001; 80 341-345
- 10 Di Re, Grosso G, Raspagliesi F, Baiocchi G. Fallopian tube cancer: incidence and role of lymphatic spread. Gynecol Oncol. 1996; 62 199-202
- 11 Gaducci A. Current management of fallopian tube carcinoma. Curr Opin Obstet Gynecol. 2002; 14 27-32
- 13 Klein M, Rosen A, Lahousen M, Graf A, Vavra N, Pakish B. Evaluation of adjuvant radiotherapy after surgery for primary carcinoma of the fallopian tube. Arch Gynecol Obstet. 1994; 255 19-24
- 14 Rawlings G, Bush R, Dembo A. Fallopian tube cancer: survival following radiation and chemotherapy. International proceedings. Cairns, Australia; Gynecologic Cancer Society 3rd Biennal Meeting 1991
- 15 Rosen A C, Klein M, Hafner E, Lahousen M, Graf A H, Reiner A. Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Obstet Invest. 1999; 47 45-51
- 16 Muntz H G, Tarraza H M, Granai C O, Fuller Jr A F. Primary adenocarcinoma of the fallopian tube. Eur J Gynaecol Oncol. 1989; 10 239-249
- 17 Rosen A C, Klein M, Lahousen M. Primary fallopian tube carcinoma in Austria - a retrospective multicenter study. Br J Cancer. 1993; 68 605-609
- 18 Beckmann M W, von Minckwitz G, Pfisterer J, Schnürch H G, Kreienberg R, Bastert G. Stellungnahme der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO): Nachsorge beim Mammakarzinom und bei gynäkologischen Malignomen - “To follow-up or not to follow-up”. Geburtsh Frauenheilk. 2003; 63 725-730
- 19 Kaum H J, Hohbach S, Wolff F. Virchow-Lymphknoten und Tubenkarzinom. Geburtsh Frauenheilk. 2001; 61 622-624
B. Kraemer
Universitaetsfrauenklinik Tuebingen
Calwer Strasse 7
72076 Tuebingen
Germany
Email: bernhardkraemer@gmx.de